Displaying 3930 results out of a total of 3930 publications.
Structure-guided design of pyridoclax derivatives based on Noxa / Mcl-1 interaction mode
Hedir, S;De Giorgi, M;Fogha, J;De Pascale, M;Weiswald, LB;Brotin, E;Marekha, B;Denoyelle, C;Denis, C;Suzanne, P;Gautier, F;Juin, P;Ligat, L;Lopez, F;Carlier, L;Legay, R;Bureau, R;Rault, S;Poulain, L;Oliveira Santos, JS;Voisin-Chiret, AS;
Eur J Med Chem, Eur J Med Chem 159():357-380, 2018
View publication
Eur J Med Chem, Eur J Med Chem 159():357-380, 2018
Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers
Baldassarre, T;Truesdell, P;Craig, AW;
Breast Cancer Res., Breast Cancer Res. 19(1):110, 2017
View publication
Breast Cancer Res., Breast Cancer Res. 19(1):110, 2017
Melanoma-derived extracellular vesicles instigate pro-inflammatory signaling in the metastatic microenvironment
Gener Lahav, T;Adler, O;Zait, Y;Shani, O;Amer, M;Doron, H;Abramovitz, L;Yofe, I;Cohen, N;Erez, N;
Int. J. Cancer, Int. J. Cancer ():, 2019
View publication
Int. J. Cancer, Int. J. Cancer ():, 2019
p38 MAPK activation through B7-H3-mediated DUSP10 repression promotes chemoresistance
Flem-Karlsen, K;Tekle, C;yjord, T;Flrenes, VA;Mlandsmo, GM;Fodstad, ;Nunes-Xavier, CE;
Sci Rep, Sci Rep 9(1):5839, 2019
View publication
Sci Rep, Sci Rep 9(1):5839, 2019
StimuliResponsive Nucleic AcidBased Polyacrylamide HydrogelCoated MetalOrganic Framework Nanoparticles for Controlled Drug Release
Chen, W;Liao, W;Sohn, YS;Fadeev, M;Cecconello, A;Nechushtai, R;Willner, I;
Advanced Functional Materials, Advanced Functional Materials ():, 2017
View publication
Advanced Functional Materials, Advanced Functional Materials ():, 2017
Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphoma
Noble, RA;Bell, N;Blair, H;Sikka, A;Thomas, H;Phillips, N;Nakjang, S;Miwa, S;Crossland, R;Rand, V;Televantou, D;Long, A;Keun, HC;Bacon, CM;Bomken, S;Critchlow, SE;Wedge, SR;
Haematologica, Haematologica 102(7):1247-1257, 2017
View publication
Haematologica, Haematologica 102(7):1247-1257, 2017
Cancer associated fibroblasts and alectinib switch the evolutionary games that non-small cell lung cancer plays
Kaznatcheev, A;Peacock, J;Basanta, D;Marusyk, A;Scott, JG;
bioRxiv, bioRxiv ():, 2017
View publication
bioRxiv, bioRxiv ():, 2017
Cellular inhibitor of apoptosis protein 2 promotes the epithelial-mesenchymal transition in triple-negative breast cancer cells through activation of the AKT signaling pathway
Jo, SJ;Park, PG;Cha, HR;Ahn, SG;Kim, MJ;Kim, H;Koo, JS;Jeong, J;Park, JH;Dong, SM;Lee, JM;
Oncotarget, Oncotarget 8(45):78781-78795, 2017
View publication
Oncotarget, Oncotarget 8(45):78781-78795, 2017
PELP1 signaling contributes to medulloblastoma progression by regulating the NF-B pathway
Luo, Y;Li, M;Pratap, UP;Viswanadhapalli, S;Liu, J;Venkata, PP;Altwegg, KA;Palacios, BE;Li, X;Chen, Y;Rao, MK;Brenner, AJ;Sareddy, GR;Vadlamudi, RK;
Mol. Carcinog., Mol. Carcinog. ():, 2019
View publication
Mol. Carcinog., Mol. Carcinog. ():, 2019
Somatic SMAD3-activating mutations cause melorheostosis by up-regulating the TGF-/SMAD pathway
Kang, H;Jha, S;Ivovic, A;Fratzl-Zelman, N;Deng, Z;Mitra, A;Cabral, W;Hanson, E;Lange, E;Cowen, E;Katz, J;Roschger, P;Klaushofer, K;Dale, R;Siegel, R;Bhattacharyya, T;Marini, J;
Journal of Experimental Medicine, Journal of Experimental Medicine 217(5):, 2020
View publication
Journal of Experimental Medicine, Journal of Experimental Medicine 217(5):, 2020